Alector, Inc.

Name: Alector, Inc. standardized financial statements, quarterly
Creator: Listed

ALECNasdaqCIK 1653087HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$3.3m, Q2 FY2026

Operating income−$24.4m, Q2 FY2026

Net income−$23.0m, Q2 FY2026

Alector, Inc., income statement, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Revenue	$m	9.1	15.2	15.9	15.1	15.3	54.2	3.7	7.9	3.3	6.2	1.0	3.3
Research and development	$m	46.3	47.7	45.2	46.3	48.0	46.5	33.6	27.6	29.4	32.5	17.9	19.5
Operating income	$m	(50.6)	(47.5)	(43.7)	(45.6)	(48.4)	(7.2)	(44.7)	(34.1)	(37.6)	(39.6)	(24.9)	(24.4)
Income tax	$m	1.3	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1
Net income	$m	(44.5)	(41.4)	(36.1)	(38.7)	(42.2)	(2.1)	(40.5)	(30.5)	(34.7)	(37.3)	(22.9)	(23.0)
Diluted EPS	$ per share	(0.53)	not reported	(0.38)	(0.40)	(0.43)	not reported	(0.41)	(0.30)	(0.34)	not reported	(0.21)	(0.21)
Basic EPS	$ per share	(0.53)	not reported	(0.38)	(0.40)	(0.43)	not reported	(0.41)	(0.30)	(0.34)	not reported	(0.21)	(0.21)

Balance sheet

Cash and equivalents$59.9m, Q2 FY2026

Long-term debt$0, Q2 FY2026

Shareholders' equity−$10.0m, Q2 FY2026

Alector, Inc., balance sheet, quarterly
Line item	Unit	Q3 FY20232023-09-30	FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Cash and equivalents	$m	102	74.6	72.6	47.5	37.2	33.0	38.0	44.8	76.5	65.8	77.0	59.9
Current assets	$m	613	566	581	520	469	425	367	319	300	266	215	180
Total assets	$m	672	622	635	571	516	468	408	356	335	293	240	203
Current liabilities	$m	155	178	165	148	143	125	110	84.4	80.0	69.5	41.0	34.2
Total liabilities	$m	510	488	457	420	397	342	314	285	278	263	230	213
Long-term debt	$m	not reported	0.0	not reported	not reported	not reported	9.4	9.5	9.5	9.6	9.3	8.3	0.0
Current portion of debt	$m	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	0.4	not reported	9.8
Short-term borrowings	$m	not reported	not reported	not reported	not reported	not reported	0.0	not reported	not reported	not reported	0.4	1.5	not reported
Shareholders' equity	$m	163	134	179	151	119	127	94.6	71.2	57.7	30.6	10.4	(10.0)

Cash flow

Operating cash flow−$34.2m, Q2 FY2026

Capital expenditure$31.0k, Q2 FY2026

Alector, Inc., cash flow, quarterly
Line item	Unit	Q3 FY20232023-09-30	Q4 FY20232023-12-31	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q4 FY20242024-12-31	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q4 FY20252025-12-31	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Operating cash flow	$m	(46.5)	(46.1)	(61.3)	(62.8)	(50.7)	(55.0)	(60.8)	(49.0)	(32.5)	(41.7)	(49.8)	(34.2)
Capital expenditure	$m	(0.1)	0.2	0.5	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0

Diluted shares (weighted)111.22m, Q2 FY2026

Alector, Inc., shares, quarterly
Line item	Unit	Q3 FY20222022-09-30	Q1 FY20232023-03-31	Q2 FY20232023-06-30	Q3 FY20232023-09-30	Q1 FY20242024-03-31	Q2 FY20242024-06-30	Q3 FY20242024-09-30	Q1 FY20252025-03-31	Q2 FY20252025-06-30	Q3 FY20252025-09-30	Q1 FY20262026-03-31	Q2 FY20262026-06-30
Diluted shares (weighted)	m shares	82.6	83.1	83.6	83.9	93.8	96.7	97.5	99.4	100	103	111	111

Shares outstanding: 111.66m at Jul 31, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:45 ET. Listed shows no prices and gives no investment advice.